EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

A Randomized Controlled Trial Evaluating Selected Ayurvedic Formulations in the Management of Yakṛt Roga w.s.r. to Non-Alcoholic Fatty Liver Disease

K. Piumi Dananga Chamari Perera, R.D.H. Kulathunga

Journal of Ayurveda and Integrated Medical Sciences · 13.12.2025 · 10 (11) · 60-70

DOI: 10.21760/jaims.10.11.7 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Ayurveda and Integrated Medical Sciences, online erschienen am 13.12.2025. Verfasst von K. Piumi Dananga Chamari Perera und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Non-alcoholic fatty liver disease (NAFLD), linked to obesity and metabolic syndrome, can progress to cirrhosis and hepatocellular carcinoma. This randomized clinical trial evaluated two Ayurvedic treatments, Phalatrikadi Kwatha with Triphala Guggulu (Group A) or Phalatrikadi Kwatha with Arogyavardhana Vati (Group B) administered in 64 patients. Primary data revealed that most participants (53.1%) were aged 61-70, 65.6% were female, and 65.6% had Grade II fatty liver. Most common symptom was identified as Abdominal discomfort, and it was (46.9%). Both groups showed significant symptom relief and Group A BMI reduction was 0.69±0.39, and Group B 0.53±0.36 (p > 0.05). ALT/SGPT levels improved significantly in Group B (37.60±14.83) compared to Group A (11.36±7.71) (p < 0.05). Improvements in AST/SGOT, GGT, ALP, serum albumin, bilirubin, and serum creatinine levels were noted in both groups and not statistically significant (p > 0.05). Ultrasound imaging showed no significant changes in liver echogenicity or parenchymal thickness. However, both treatments effectively managed NAFLD, with Group B showing superior improvement in liver function, particularly ALT/SGPT levels, and demonstrating its potential as a therapeutic option for NAFLD.

Zitieren

APA

Perera, K. P. D. C., & Kulathunga, R. (2025). A Randomized Controlled Trial Evaluating Selected Ayurvedic Formulations in the Management of Yakṛt Roga w.s.r. to Non-Alcoholic Fatty Liver Disease. Journal of Ayurveda and Integrated Medical Sciences, 10(11), 60-70. https://doi.org/10.21760/jaims.10.11.7

Vancouver

Perera KPDC, Kulathunga R. A Randomized Controlled Trial Evaluating Selected Ayurvedic Formulations in the Management of Yakṛt Roga w.s.r. to Non-Alcoholic Fatty Liver Disease. Journal of Ayurveda and Integrated Medical Sciences. 2025;10(11):60-70. doi:10.21760/jaims.10.11.7

BibTeX
@article{Perera2025,
  author = {Perera, K. Piumi Dananga Chamari and Kulathunga, R.D.H.},
  title = {A Randomized Controlled Trial Evaluating Selected Ayurvedic Formulations in the Management of Yakṛt Roga w.s.r. to Non-Alcoholic Fatty Liver Disease},
  journal = {Journal of Ayurveda and Integrated Medical Sciences},
  year = {2025},
  volume = {10},
  number = {11},
  pages = {60--70},
  doi = {10.21760/jaims.10.11.7}
}
Kostenlos starten →